11 – 17 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2021
-
Mark
Elevated circulating follistatin associates with an increased risk of type 2 diabetes
(
- Contribution to journal › Article
- 2020
-
Mark
Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors
(
- Contribution to journal › Article
- 2019
-
Mark
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes : A nested, case–control study
(
- Contribution to journal › Article
- 2018
-
Mark
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes : The SUMMIT VIP Study
(
- Contribution to journal › Article
-
Mark
Development and validation of a path length calculation for carotid-femoral pulse wave velocity measurement : A TASCFORCE, SUMMIT, and caerphilly collaborative venture
(
- Contribution to journal › Article
- 2016
-
Mark
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »